These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35789220)

  • 1. Resuscitation simulation among people who are likely to witness opioid overdose: Experiences from the SOONER Trial.
    Whittall JP; Orkin AM; Handford C; Klaiman M; Leece P; Charles M; Wright A; Turner S; Morrison LJ; Strike C; Campbell DM
    PLoS One; 2022; 17(7):e0270829. PubMed ID: 35789220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for a mixed-methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) randomised control trial.
    Orkin A; Campbell D; Handford C; Hopkins S; Klaiman M; Leece P; Parsons JA; Shahin R; Strike C; Thorpe K; Sellen K; Milos G; Wright A; Charles M; Sniderman R; Morrison L;
    BMJ Open; 2019 Nov; 9(11):e029436. PubMed ID: 31722937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) trial.
    Orkin AM; Charles M; Norris K; Thomas R; Chapman L; Wright A; Campbell DM; Handford C; Klaiman M; Hopkins S; Shahin R; Thorpe K; Jüni P; Parsons J; Sellen K; Goso N; Hunt R; Leece P; Morrison LJ; Stergiopoulos V; Turner S; Strike C
    Resusc Plus; 2021 Jun; 6():100131. PubMed ID: 34223388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.
    Parkin S; Neale J; Brown C; Jones JD; Brandt L; Castillo F; Campbell ANC; Strang J; Comer SD
    Int J Drug Policy; 2021 Jan; 87():102968. PubMed ID: 33096365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
    Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
    J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis.
    Neale J; Kalk NJ; Parkin S; Brown C; Brandt L; Campbell ANC; Castillo F; Jones JD; Strang J; Comer SD
    J Subst Abuse Treat; 2020 Oct; 117():108099. PubMed ID: 32811629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degree of Bystander-Patient Relationship and Prehospital Care for Opioid Overdose.
    McCann MK; Jusko TA; Jones CMC; Seplaki CL; Cushman JT
    Prehosp Emerg Care; 2021; 25(1):82-90. PubMed ID: 32073921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies.
    Neale J; Brown C; Campbell ANC; Jones JD; Metz VE; Strang J; Comer SD
    Addiction; 2019 Apr; 114(4):708-718. PubMed ID: 30476356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
    Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
    BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment.
    Bounthavong M; Suh K; Christopher MLD; Veenstra DL; Basu A; Devine EB
    Res Social Adm Pharm; 2020 Aug; 16(8):1033-1040. PubMed ID: 31706950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
    Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
    Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of an Opioid Overdose and Naloxone Distribution Training in a Pharmacist Laboratory Course.
    Kwon M; Moody AE; Thigpen J; Gauld A
    Am J Pharm Educ; 2020 Feb; 84(2):7179. PubMed ID: 32226065
    [No Abstract]   [Full Text] [Related]  

  • 13. Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia.
    Kanter K; Gallagher R; Eweje F; Lee A; Gordon D; Landy S; Gasior J; Soto-Calderon H; Cronholm PF; Cocchiaro B; Weimer J; Roth A; Lankenau S; Brenner J
    Harm Reduct J; 2021 Jul; 18(1):75. PubMed ID: 34301246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario.
    Leece PN; Hopkins S; Marshall C; Orkin A; Gassanov MA; Shahin RM
    Can J Public Health; 2013 Apr; 104(3):e200-4. PubMed ID: 23823882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Narcan encounters:" overdose and naloxone rescue experiences among people who use opioids.
    Kahn LS; Wozniak M; Vest BM; Moore C
    Subst Abus; 2022; 43(1):113-126. PubMed ID: 32243234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the take ACTION Train-the-Trainer model of opioid overdose education with naloxone distribution- who benefits?
    Dahlem CH; Scalera M; Chen B; McCabe SE; Boyd CJ
    Subst Abus; 2020; 41(4):485-492. PubMed ID: 31638875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overdose Education and Naloxone Distribution Program Attendees: Who Attends, What Do They Know, and How Do They Feel?
    Heavey SC; Burstein G; Moore C; Homish GG
    J Public Health Manag Pract; 2018; 24(1):63-68. PubMed ID: 28257406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts.
    Sumner SA; Mercado-Crespo MC; Spelke MB; Paulozzi L; Sugerman DE; Hillis SD; Stanley C
    Prehosp Emerg Care; 2016; 20(2):220-5. PubMed ID: 26383533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment.
    Drainoni ML; Koppelman EA; Feldman JA; Walley AY; Mitchell PM; Ellison J; Bernstein E
    BMC Res Notes; 2016 Oct; 9(1):465. PubMed ID: 27756427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More than saving lives: Qualitative findings of the UNODC/WHO Stop Overdose Safely (S-O-S) project.
    Walker S; Dietze P; Poznyak V; Campello G; Kashino W; Dzhonbekov D; Kiriazova T; Nikitin D; Terlikbayeva A; Nevendorff L; Busse A; Krupchanka D
    Int J Drug Policy; 2022 Feb; 100():103482. PubMed ID: 35042142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.